{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:10:26Z","timestamp":1759403426936,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.10.060","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T09:12:29Z","timestamp":1574068349000},"page":"2088-2094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014\u201315"],"prefix":"10.1016","volume":"38","author":[{"given":"Kelsey","family":"Florek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Mutschler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2725-6439","authenticated-orcid":false,"given":"Huong Q.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer P.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Flannery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Belongia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-6895","authenticated-orcid":false,"given":"Thomas C.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2019.10.060_b0005","doi-asserted-by":"crossref","first-page":"D31","DOI":"10.1016\/j.vaccine.2008.07.078","article-title":"Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses","volume":"26","author":"Russell","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.060_b0010","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2019.10.060_b0015","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","article-title":"Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children","volume":"30","author":"Black","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.10.060_b0020","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/infdis\/jir661","article-title":"Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection","volume":"204","author":"Ohmit","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.060_b0025","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2019.10.060_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines6030036","article-title":"The role of Fc gamma receptors in broad protection against influenza viruses","author":"Thulin","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2019.10.060_b0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fimmu.2019.00440","article-title":"Extra-neutralizing FcR-mediated antibody functions for a universal influenza vaccine","volume":"10","author":"Boudreau","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.10.060_b0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.10.060_b0045","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2019.10.060_b0050","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1172\/JCI111518","article-title":"Membrane-bound hemagglutinin mediates antibody and complement-dependent lysis of influenza virus-treated human platelets in autologous serum","volume":"74","author":"Kazatchkine","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2019.10.060_b0055","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.10.060_b0060","doi-asserted-by":"crossref","first-page":"e0154461","DOI":"10.1371\/journal.pone.0154461","article-title":"Influenza-specific antibody-dependent phagocytosis","volume":"11","author":"Ana-Sosa-Batiz","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.10.060_b0065","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/infdis\/148.5.785","article-title":"Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells","volume":"148","author":"Hashimoto","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.060_b0070","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/infdis\/jiw262","article-title":"Generation and protective ability of influenza virus-specific antibody-dependent cellular cytotoxicity in humans elicited by vaccination, natural infection, and experimental challenge","volume":"214","author":"Jegaskanda","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.060_b0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/vim.2016.0003","article-title":"Vaccination with 2014\u201315 seasonal inactivated influenza vaccine elicits cross-reactive anti-HA antibodies with strong ADCC against antigenically drifted circulating H3N2 virus in humans","volume":"29","author":"Zhong","year":"2016","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2019.10.060_b0080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.vaccine.2016.11.082","article-title":"Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection","volume":"35","author":"de Vries","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.060_b0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coviro.2016.12.002","article-title":"Antibody-dependent cellular cytotoxicity and influenza virus","volume":"22","author":"Vanderven","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2019.10.060_b0090","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciw635","article-title":"2014\u20132015 influenza vaccine effectiveness in the United States by vaccine type","volume":"63","author":"Zimmerman","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.060_b0095","article-title":"Association of prior vaccination with influenza vaccine effectiveness in children receiving live attenuated or inactivated vaccine","volume":"1","author":"McLean","year":"2018","journal-title":"JAMANetw Open"},{"key":"10.1016\/j.vaccine.2019.10.060_b0100","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.vaccine.2018.01.016","article-title":"Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013\u20132014 season","volume":"36","author":"King","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.060_b0105","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/irv.12593","article-title":"Validation of self-reported influenza vaccination in the current and prior season","volume":"12","author":"King","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2019.10.060_b0110","first-page":"691","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) \u2013 United States, 2014\u201315 influenza season","volume":"63","author":"Grohskopf","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.vaccine.2019.10.060_b0115","article-title":"Effect of previous-season influenza vaccination on serologic response in children during 3 seasons, 2013\u20132014 through 2015\u20132016","author":"McLean","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2019.10.060_b0120","doi-asserted-by":"crossref","first-page":"13418","DOI":"10.1128\/JVI.01219-14","article-title":"Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques","volume":"88","author":"Florek","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.10.060_b0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.virol.2014.12.024","article-title":"Structure and receptor binding preferences of recombinant human A(H3N2) virus hemagglutinins","volume":"477","author":"Yang","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.10.060_b0130","doi-asserted-by":"crossref","first-page":"12039","DOI":"10.1128\/JVI.01650-12","article-title":"A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays","volume":"86","author":"Alpert","year":"2012","journal-title":"J Virol."},{"year":"2016","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","key":"10.1016\/j.vaccine.2019.10.060_b0135"},{"key":"10.1016\/j.vaccine.2019.10.060_b0140","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1128\/JVI.03030-12","article-title":"Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques","volume":"87","author":"Jegaskanda","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.10.060_b0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/infdis\/jix554","article-title":"Antibody-dependent cellular cytotoxicity responses to seasonal influenza vaccination in older adults","volume":"217","author":"Vanderven","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.060_b0150","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/infdis\/jiy214","article-title":"Induction of cross-clade antibody and T-cell responses by a modified vaccinia virus ankara-based influenza A(H5N1) vaccine in a randomized phase 1\/2a clinical trial","volume":"218","author":"de Vries","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.060_b0155","doi-asserted-by":"crossref","first-page":"e12801","DOI":"10.1111\/sji.12801","article-title":"Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination","volume":"90","author":"Islam","year":"2019","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2019.10.060_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181738","article-title":"A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques","volume":"12","author":"Florek","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.10.060_b0165","doi-asserted-by":"crossref","first-page":"13706","DOI":"10.1128\/JVI.01666-13","article-title":"Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques","volume":"87","author":"Jegaskanda","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.10.060_b0170","doi-asserted-by":"crossref","first-page":"E5944","DOI":"10.1073\/pnas.1613225113","article-title":"Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact","volume":"113","author":"Leon","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.vaccine.2019.10.060_b0175","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A universal influenza vaccine: the strategic plan for the national institute of allergy and infectious diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:41:19Z","timestamp":1759401679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19314409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X19314409"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014\u201315","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}